BERINERT 500 500UI powder + solvent for injection / infusion solution medication leaflet

B06AC01 human C1 esterase inhibitor • Blood and blood forming organs | Other hematological agents | Drugs used in hereditary angioedema

Human C1 esterase inhibitor is used for the treatment of hereditary angioedema, a genetic condition characterized by recurrent episodes of severe swelling. It works by regulating the activity of the complement system and preventing its excessive activation.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.

Side effects may include headache, nausea, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.

This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.

General data about BERINERT 500 500UI

Substance: human C1 esterase inhibitor

Date of last drug list: 01-06-2025

Commercial code: W58531001

Concentration: 500UI

Pharmaceutical form: powder + solvent for injection / infusion solution

Quantity: 1

Product type: original

Price: 2533.48 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CSL BEHRING GMBH - GERMANIA

Holder: CSL BEHRING GMBH - GERMANIA

Number: 7182/2014/01

Shelf life: 30 months

Pharmaceutical forms available for human C1 esterase inhibitor

Concentrations available for human C1 esterase inhibitor

1500UI, 2000UI, 3000UI, 500 U, 500UI

Other substances similar to human C1 esterase inhibitor

Compensation lists for BERINERT 500 500UI CSL BEHRING

NHP 6.22 (C2) - Hereditary angioedema

Price

Copayment

Patient

2533.48 RON

2533.48 RON

0.00 RON